Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rangering i aksjer #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aksjekurs
$0.21291741
Sist synkronisert: 2025-04-18
Markedsverdi
$12.07M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Kategori

Healthcare
P/S-forhold for PCL, Inc. (241820)
P/S-forhold per August 2026 TTM: 3.15
Ifølge PCL, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 3.15. Ved slutten av 2023 hadde selskapet et P/S-forhold på 18.24.
P/S-historikk for PCL, Inc. fra 2015 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 3.15 -87.36%
2024 24.96 36.88%
2023 18.24 283.15%
2022 4.76 -45.57%
2021 8.74 19.24%
2020 7.33 -99.68%
2019 2.28K 207.15%
2018 742.49 119.01%
2017 339.03 117.88%
2016 155.60 -58.72%
2015 376.97 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 30.99%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 59.53%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -11.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 16.30%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 156.71%
US